Your browser is no longer supported. Please, upgrade your browser.
Settings
PMVP [NASD]
PMV Pharmaceuticals, Inc.
Index- P/E25.56 EPS (ttm)1.34 Insider Own10.90% Shs Outstand44.78M Perf Week-3.50%
Market Cap1.45B Forward P/E- EPS next Y-1.63 Insider Trans-14.78% Shs Float39.65M Perf Month1.63%
Income-38.80M PEG1.11 EPS next Q-0.27 Inst Own89.30% Short Float7.73% Perf Quarter1.33%
Sales- P/S- EPS this Y-30.50% Inst Trans0.48% Short Ratio9.35 Perf Half Y-17.10%
Book/sh7.78 P/B4.40 EPS next Y-38.10% ROA- Target Price61.67 Perf Year-
Cash/sh7.82 P/C4.38 EPS next 5Y23.10% ROE- 52W Range26.38 - 63.22 Perf YTD-44.35%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-45.86% Beta-
Dividend %- Quick Ratio57.80 Sales past 5Y- Gross Margin- 52W Low29.76% ATR2.06
Employees44 Current Ratio57.80 Sales Q/Q- Oper. Margin- RSI (14)51.12 Volatility6.37% 6.26%
OptionableYes Debt/Eq0.00 EPS Q/Q89.10% Profit Margin- Rel Volume1.47 Prev Close34.88
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume327.46K Price34.23
Recom2.00 SMA201.19% SMA501.53% SMA200-7.80% Volume474,108 Change-1.86%
Oct-20-20Initiated Goldman Neutral $34
Oct-20-20Initiated Evercore ISI Outperform $60
Oct-20-20Initiated Cowen Outperform
Oct-20-20Initiated BofA Securities Buy $42
Jul-19-21 06:19PM  
Jun-23-21 05:38AM  
Jun-09-21 08:00AM  
Jun-03-21 08:00AM  
May-14-21 08:00AM  
May-05-21 08:00AM  
Apr-10-21 01:31PM  
Apr-06-21 08:00AM  
Mar-10-21 04:31PM  
Mar-03-21 04:01PM  
Feb-16-21 08:00AM  
Dec-25-20 03:44AM  
Dec-16-20 03:19PM  
Nov-24-20 05:00PM  
Nov-23-20 08:00AM  
Nov-13-20 08:00AM  
Oct-13-20 08:00AM  
Oct-09-20 03:41PM  
Oct-01-20 11:57AM  
Sep-29-20 04:05PM  
Sep-25-20 02:31PM  
12:37PM  
06:16AM  
Sep-24-20 08:06PM  
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores p53 function. It is also developing p53 R273H mutation and other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schroeder ThiloDirectorJul 27Sale35.6153519,0512,002,295Jul 27 06:20 PM
Schroeder ThiloDirectorJul 26Sale35.734,839172,8972,002,830Jul 27 06:20 PM
Schroeder ThiloDirectorJul 23Sale36.0011,988431,5682,007,669Jul 27 06:20 PM
Schroeder ThiloDirectorJul 22Sale35.612007,1222,019,657Jul 23 05:32 PM
Mack David HenryPresident and CEOJul 21Option Exercise0.5326,76714,18739,237Jul 22 04:24 PM
Mack David HenryPresident and CEOJul 21Sale35.7626,767957,09212,470Jul 22 04:24 PM
Schroeder ThiloDirectorJul 21Sale35.8218,672668,8312,019,857Jul 23 05:32 PM
Mack David HenryPresident and CEOJul 20Option Exercise0.531,02954513,499Jul 22 04:24 PM
Mack David HenryPresident and CEOJul 20Sale35.531,02936,56012,470Jul 22 04:24 PM
LEVINE ARNOLD JDirectorJul 20Sale35.123,500122,929416,842Jul 22 04:28 PM
Kung WinstonCOO, CFOJul 08Option Exercise3.224,50014,4906,100Jul 08 07:04 PM
Kung WinstonCOO, CFOJul 08Sale33.754,500151,8751,600Jul 08 07:04 PM
Alland LeilaChief Medical OfficerJul 07Option Exercise3.904,00015,6004,000Jul 08 04:10 PM
Alland LeilaChief Medical OfficerJul 07Sale32.304,000129,2130Jul 08 04:10 PM
Mack David HenryPresident and CEOJun 28Option Exercise0.5320410812,674Jun 29 06:09 PM
Mack David HenryPresident and CEOJun 28Sale35.532047,24812,470Jun 29 06:09 PM
LEVINE ARNOLD JDirectorJun 21Sale33.253,500116,362420,342Jun 22 05:24 PM
Euclidean Capital LLC10% OwnerJun 14Sale34.1144,4191,515,132127,099Jun 15 06:58 PM
Euclidean Capital LLC10% OwnerJun 11Sale33.8021,977742,823128,359Jun 15 06:58 PM
Euclidean Capital LLC10% OwnerJun 10Sale32.6820,633674,286129,980Jun 11 05:35 PM
Euclidean Capital LLC10% OwnerJun 09Sale33.6439,6381,333,422129,565Jun 11 05:35 PM
Euclidean Capital LLC10% OwnerJun 08Sale33.3831,7241,058,947130,686Jun 09 06:17 PM
Alland LeilaChief Medical OfficerJun 07Option Exercise3.904,00015,6004,000Jun 08 07:22 PM
Alland LeilaChief Medical OfficerJun 07Sale33.604,000134,3870Jun 08 07:22 PM
Euclidean Capital LLC10% OwnerJun 07Sale33.6230,7211,032,840131,582Jun 09 06:17 PM
Kung WinstonCOO, CFOJun 04Option Exercise3.224,50014,4906,100Jun 07 09:36 PM
Kung WinstonCOO, CFOJun 04Sale33.754,500151,8751,600Jun 07 09:36 PM
Heyman Richard A.DirectorJun 01Option Exercise245.963,900959,2541,950Jun 02 04:11 PM
Heyman Richard A.DirectorJun 01Sale32.553,900126,9350Jun 02 04:11 PM
Schroeder ThiloDirectorMay 28Sale35.805,100182,5802,038,529Jun 02 06:07 PM
Schroeder ThiloDirectorMay 26Sale35.667,487266,9862,043,629May 27 07:41 PM
Schroeder ThiloDirectorMay 25Sale35.918,518305,8812,051,116May 27 07:41 PM
Schroeder ThiloDirectorMay 24Sale36.0322,095796,0832,059,634May 24 07:59 PM
Mack David HenryPresident and CEOMay 21Option Exercise0.536,2073,2908,677May 24 04:52 PM
Schroeder ThiloDirectorMay 21Sale35.8419,774708,7002,081,729May 24 07:59 PM
Mack David HenryPresident and CEOMay 21Sale35.716,207221,6412,470May 24 04:52 PM
Mack David HenryPresident and CEOMay 20Option Exercise0.537,7934,13010,263May 24 04:52 PM
Mack David HenryPresident and CEOMay 20Option Exercise0.5310,0005,30012,470Jun 04 07:13 PM
LEVINE ARNOLD JDirectorMay 20Sale34.513,500120,768423,842May 21 05:38 PM
Schroeder ThiloDirectorMay 20Sale35.652,911103,7772,101,503May 24 07:59 PM
Mack David HenryPresident and CEOMay 20Sale35.607,793277,4552,470May 24 04:52 PM
Schroeder ThiloDirectorMay 10Sale35.671,78763,7422,104,414May 12 07:46 PM
Alland LeilaChief Medical OfficerMay 07Option Exercise3.904,00015,6004,000May 10 05:06 PM
Alland LeilaChief Medical OfficerMay 07Sale34.834,000139,3090May 10 05:06 PM
Schroeder ThiloDirectorMay 05Sale35.6460021,3842,106,201May 07 06:56 PM
Kung WinstonCOO, CFOMay 03Option Exercise3.224,50014,4906,100May 04 07:22 PM
Kung WinstonCOO, CFOMay 03Sale33.754,500151,8751,600May 04 07:22 PM
Schroeder ThiloDirectorApr 12Sale31.413,903122,5982,106,801Apr 13 09:07 PM
Schroeder ThiloDirectorApr 09Sale34.6325,763892,1392,110,704Apr 13 09:07 PM
Schroeder ThiloDirectorApr 08Sale34.0733,3221,135,4372,136,467Apr 08 07:24 PM
Alland LeilaChief Medical OfficerApr 07Option Exercise3.904,00015,6004,000Apr 08 04:13 PM
Alland LeilaChief Medical OfficerApr 07Sale33.864,000135,4450Apr 08 04:13 PM
Schroeder ThiloDirectorApr 07Sale33.8824,457828,6652,169,789Apr 08 07:24 PM
Schroeder ThiloDirectorApr 06Sale34.5578,6572,717,5502,194,246Apr 08 07:24 PM
Schroeder ThiloDirectorApr 05Sale33.8148,1931,629,1832,272,903Apr 05 07:04 PM
Schroeder ThiloDirectorApr 01Sale32.9412,435409,6092,321,096Apr 05 07:04 PM
Schroeder ThiloDirectorMar 31Sale32.5233,6261,093,4922,333,531Mar 31 09:25 PM
Schroeder ThiloDirectorMar 30Sale30.8722,483694,1382,367,157Mar 31 09:25 PM
Schroeder ThiloDirectorMar 29Sale32.152,17469,8902,389,640Mar 31 09:25 PM
Schroeder ThiloDirectorMar 26Sale33.4435,2681,179,3622,391,814Mar 26 06:20 PM
Schroeder ThiloDirectorMar 25Sale33.0466,3272,191,7252,427,082Mar 26 06:20 PM
Schroeder ThiloDirectorMar 24Sale36.5034,8811,273,0432,493,409Mar 26 06:20 PM
Kung WinstonCOO, CFODec 08Option Exercise3.221,6005,1521,600Dec 31 04:25 PM
Mack David HenryPresident and CEONov 18Option Exercise0.532,4701,3092,470Nov 20 04:12 PM